leadf
logo-loader
viewArix Bioscience PLC

Proactive meets Arix Bioscience's new chairman and hears why he's bullish on its portfolio

Proactive London's Andrew Scott chats to Arix Bioscience PLC's (LON:ARIX) chairman Naseem Amin who took on the role in April this year.

He discusses some of the recent significant changes at the group including its entrepreneur-in-residence, Christian Schetter, who's been appointed managing director of the venture capital company alongside Jonathan Tobin as well as the establishment of both a scientific advisory board (SAB) and a board investment committee (BIC).

Quick facts: Arix Bioscience PLC

Price: 105.5 GBX

LSE:ARIX
Market: LSE
Market Cap: £143.12 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arix Bioscience PLC named herein, including the promotion by the Company of Arix Bioscience PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Market report: FTSE flounders as imminent Brexit talks loom

The FTSE is mixed this Tuesday despite the weaker pound. Sterling is still battling no deal Brexit fears as the UK Prime Minister Boris Johnson threatens that if no progress on the talks with the EU is made week, preparations for a no deal will be ramped up. Britain’s biggest sports retailer...

on 8/9/20

2 min read